The NAFLD model group exhibited significant upregulation of key genes involved in lipid biosynthesis (Acc1, Fasn, Slc27a2, and Srebf1) (p < 0.01) and a downregulation of CPT1α (p < 0.01), compared to the control group. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.